Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

Pharmaceutical Economics and Policy

27 ta ish

  1. Pharmacoeconomics and the Patients’ Compliance as an Essential part of Successful therapy of iron Deficiency Anemia.

    Khodjieva Gulirano Sayfullaevna

    MaqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeIndonesian Journal of Innovation Studies20221 iqtibos
    ABI

  2. Enhancing global access to cancer medicines

    Javier Cortés, José Manuel Pérez-García, Antonio Llombart‐Cussac +13

    Sharh maqolaOchiq kirishEconomic and Financial Impacts of CancerCA A Cancer Journal for Clinicians20201 iqtibos
    ABI

  3. Shortages and price variability of essential cytotoxic medicines for treating children with cancers

    Yehoda M. Martei, Kotoji Iwamoto, Ronald D. Barr +2

    MaqolaOchiq kirishPharmaceutical Economics and PolicyBMJ Global Health20201 iqtibos
    ABI

  4. 563 Long-term acceptance of nebivolol in idiopathic dilated cardiomyopathy patients

    Т. А. Абдуллаев, Н. А. Курбанов, I. R. Bekbulatova +1

    MaqolaHeart Failure Treatment and ManagementEuropean Journal of Heart Failure Supplements20060 iqtibos
    ABI

  5. A Status Report on the Health Care Sector in France

    N. Lalitha, Samira Guennif

    MaqolaPharmaceutical Economics and PolicyJournal of Health Management20080 iqtibos
    ABI

  6. The Politics and Strategy of Industry Self-Regulation: The Pharmaceutical Industry's Principles for Ethical Direct-to-Consumer Advertising as a Deceptive Blocking Strategy

    Denis Arnold, James L. Oakley

    MaqolaPharmaceutical industry and healthcareJournal of Health Politics Policy and Law20130 iqtibos
    ABI

  7. P767Efficacy and safety of switching simvastatin intolerant patients with coronary artery disease to rosuvastatin treatment

    Aleksandr B. Shek, Р. Д. Курбанов, G J Abdullaeva +3

    MaqolaLipoproteins and Cardiovascular HealthEuropean Heart Journal20170 iqtibos
    ABI

  8. PO432 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)

    G. Nagaeva, S. Nagaev

    MaqolaPharmaceutical Economics and PolicyGlobal Heart20180 iqtibos
    ABI

  9. PO433 Compliance With Drug Therapy In Relation to Acute Coronary Events (A Fragment of the Register RACSMI-Uz)

    G. Nagaeva, S. Nagaev

    MaqolaPharmaceutical Economics and PolicyGlobal Heart20180 iqtibos
    ABI

  10. Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action

    Jane Robertson, Kotoji Iwamoto, Iris Hoxha +18

    MaqolaOchiq kirishAntibiotic Use and ResistanceFrontiers in Pharmacology20190 iqtibos
    ABI

  11. PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW

    S. Djalalov, Dilfuza Djalalova, Murray Krahn +2

    MaqolaOchiq kirishHealth Systems, Economic Evaluations, Quality of LifeValue in Health20190 iqtibos
    ABI

  12. O'zbekistonda farmasevtika sanoatining rivojlanishi

    Sh. Yakubova

    MaqolaOchiq kirishPharmaceutical Economics and PolicyОбщество и инновации20210 iqtibos
    ABI

  13. Sudden Spurt in Pediatric Patients with AKI in Uzbekistan: A Call for International Drug Quality Control and Pharmaceutical Legislation

    Nodira Murtalibova, Sidharth Kumar Sethi, Rupesh Raina +2

    MaqolaOchiq kirishPharmaceutical Quality and CounterfeitingKidney36020230 iqtibos
    ABI

  14. AVAILABILITY AND COSTS OF MEDICINES FOR THE TREATMENT OF TUBERCULOSIS

    Batirova Barchinoy Tadjimukhammadovna

    MaqolaOchiq kirishTuberculosis Research and EpidemiologyInternational Journal of Medical Sciences And Clinical Research20240 iqtibos
    ABI

  15. Content analysis of anticancer drugs of the pharmaceutical market of the republic of Uzbekistan

    Шохиста Шарофиддин кизи Мелибоева, Мизроб Мавлонович Болтаев, Umida Narzulaeva

    MaqolaOchiq kirishPharmaceutical Economics and PolicyBIO Web of Conferences20240 iqtibos
    ABI

  16. Fınancıal sustaınabılıty and rısk in antı-agıng startups

    Mehmet Mustafa Besirikli

    MaqolaOchiq kirishPharmaceutical Economics and PolicyJournal of Forensic Accounting Profession20240 iqtibos
    ABI

  17. Drug-drug interactions in clinical practice: a literature review and SWOT analysis

    Valeriya O. Barysheva, О. S. Golikova, В. Г. Кудрина +1

    Sharh maqolaOchiq kirishPharmaceutical Practices and Patient OutcomesMedical Technologies Assessment and Choice20240 iqtibos
    ABI

  18. Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies

    Homie Razavi, Imam Waked, Huma Qureshi +97

    MaqolaOchiq kirishHepatitis C virus researchJournal of Hepatology20250 iqtibos
    ABI

  19. EXPERIMENTAL ESTIMATION OF THE EFFICIENCY OF NEW POLICY IN THE PHARMACEUTICAL INDUSTRY

    Sokhibmalik Khomidov

    MaqolaPharmaceutical Economics and PolicyЭкономика и предпринимательство20250 iqtibos
    ABI

  20. The Range of Medicines in The City of Samarkand: A Marketing Analysis

    Makhmudova Maftuna Mehrojovna, Rayimqulova Ch.A.

    MaqolaOchiq kirishEducational Management and QualityEuropean International Journal of Multidisciplinary Research and Management Studies20250 iqtibos
    ABI

  21. Blood-pressure and cholesterol lowering therapy with polypill and separate drug, their comparative effectiveness in persons with hypertension and dyslipidemia

    Shakhlo Fayzullaeva, Г А Хамидуллаева

    MaqolaMedication Adherence and ComplianceAtherosclerosis20250 iqtibos
    ABI

  22. Validation of Kazakh and Russian Generic Drug Questionnaire

    Zhandulla Nakipov, U. N. Musaev, Indira Smagylova +7

    MaqolaOchiq kirishPharmaceutical Economics and PolicyMedical Journal of the Islamic Republic of Iran20250 iqtibos
    ABI

  23. Comparative Analysis of the Efficacy of a Polypill and a Free Combination of Antihypertensive Drugs and Statins in the Context of an Individualized Treatment Strategy

    Shakhlo S. Fayzullaeva, Gulnoz A. Khamidullaeva, Guzal Zh. Abdullaeva +2

    MaqolaOchiq kirishPharmaceutical Economics and PolicyInternational Journal of Biomedicine20250 iqtibos
    ABI

  24. STAGES OF DEVELOPMENT OF NEW MEDICINAL PRODUCTS

    A.K. SADANOV, B.B. BAIMAKHANOVA, Z.Zh. TURLYBAYEVA +2

    MaqolaOchiq kirishPharmaceutical Quality and CounterfeitingМИКРОБИОЛОГИЯ ЖӘНЕ ВИРУСОЛОГИЯ20250 iqtibos
    ABI

  25. Rare diseases as a global priority: the CIS Orphan Forum and the path toward collaboration with BRICS

    Nuriya Z. Musina, Ahmed Al Saidi, Ayman W. El-Hattab +27

    MaqolaOchiq kirishGenomics and Rare DiseasesThe BRICS Health Journal20260 iqtibos
    ABI